Your browser doesn't support javascript.
loading
Combination therapy of lovastatin and AMP-activated protein kinase activator improves mitochondrial and peroxisomal functions and clinical disease in experimental autoimmune encephalomyelitis model.
Singh, Inderjit; Samuvel, Devadoss J; Choi, Seungho; Saxena, Nishant; Singh, Avtar K; Won, Jeseong.
Affiliation
  • Singh I; Charles P. Darby Children's Research Institute, Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA.
  • Samuvel DJ; Research Service, Ralph H. Johnson Veterans Administration Medical Center, Charleston, SC, USA.
  • Choi S; Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, USA.
  • Saxena N; Charles P. Darby Children's Research Institute, Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA.
  • Singh AK; Charles P. Darby Children's Research Institute, Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA.
  • Won J; Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, USA.
Immunology ; 154(3): 434-451, 2018 07.
Article in En | MEDLINE | ID: mdl-29331024
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lovastatin / Peroxisomes / AMP-Activated Protein Kinases / Mitochondria Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Immunology Year: 2018 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lovastatin / Peroxisomes / AMP-Activated Protein Kinases / Mitochondria Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Immunology Year: 2018 Type: Article Affiliation country: United States